196 related articles for article (PubMed ID: 20964473)
1. Costs of heart failure-related hospitalizations in patients aged 18 to 64 years.
Wang G; Zhang Z; Ayala C; Wall HK; Fang J
Am J Manag Care; 2010 Oct; 16(10):769-76. PubMed ID: 20964473
[TBL] [Abstract][Full Text] [Related]
2. Resource use in the last 6 months of life among patients with heart failure in Canada.
Kaul P; McAlister FA; Ezekowitz JA; Bakal JA; Curtis LH; Quan H; Knudtson ML; Armstrong PW
Arch Intern Med; 2011 Feb; 171(3):211-7. PubMed ID: 20937918
[TBL] [Abstract][Full Text] [Related]
3. Resource utilization in patients hospitalized with heart failure: insights from a contemporary national hospital database.
Hauptman PJ; Swindle J; Burroughs TE; Schnitzler MA
Am Heart J; 2008 Jun; 155(6):978-985.e1. PubMed ID: 18513507
[TBL] [Abstract][Full Text] [Related]
4. [Health economic impact of heart failure: An analysis of the nationwide German database].
Zugck C; Müller A; Helms TM; Wildau HJ; Becks T; Hacker J; Haag S; Goldhagen K; Schwab JO
Dtsch Med Wochenschr; 2010 Apr; 135(13):633-8. PubMed ID: 20333603
[TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of IDPN therapy measured by hospitalizations and length of stay.
Cranford W
Nephrol News Issues; 1998 Sep; 12(9):33-5, 37-9. PubMed ID: 9923295
[No Abstract] [Full Text] [Related]
7. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
Caro JJ; Migliaccio-Walle K; O'Brien JA; Nova W; Kim J; Hauch O; Hillson E; Wedel H; Hjalmarson A; Gottlieb S; Deedwania PC; Wikstrand J;
J Card Fail; 2005 Dec; 11(9):647-56. PubMed ID: 16360958
[TBL] [Abstract][Full Text] [Related]
8. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with hospital length of stay and hospital charges of motor vehicle crash related hospitalizations among children in the United States.
Gardner R; Smith GA; Chany AM; Fernandez SA; McKenzie LB
Arch Pediatr Adolesc Med; 2007 Sep; 161(9):889-95. PubMed ID: 17768290
[TBL] [Abstract][Full Text] [Related]
10. Variations in and correlates of length of stay in academic hospitals among patients with heart failure resulting from systolic dysfunction.
Krumholz HM; Chen YT; Bradford WD; Cerese J
Am J Manag Care; 1999 Jun; 5(6):715-23. PubMed ID: 10538451
[TBL] [Abstract][Full Text] [Related]
11. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
Reed SD; Friedman JY; Velazquez EJ; Gnanasakthy A; Califf RM; Schulman KA
Am Heart J; 2004 Jul; 148(1):122-8. PubMed ID: 15215801
[TBL] [Abstract][Full Text] [Related]
12. Depression and negative outcomes in patients with heart failure.
Rozzini R; Trabucchi M
Arch Intern Med; 2003 Feb; 163(4):498; author reply 499. PubMed ID: 12588216
[No Abstract] [Full Text] [Related]
13. Burden of encephalitis-associated hospitalizations in the United States, 1988-1997.
Khetsuriani N; Holman RC; Anderson LJ
Clin Infect Dis; 2002 Jul; 35(2):175-82. PubMed ID: 12087524
[TBL] [Abstract][Full Text] [Related]
14. National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures.
Becker ER
J Health Care Finance; 2007; 33(3):1-16. PubMed ID: 19175228
[TBL] [Abstract][Full Text] [Related]
15. Impact of heart failure on hospital activity and healthcare costs in Belgium.
Claes N; Jacobs N; Vijgen J
J Med Econ; 2008; 11(1):71-9. PubMed ID: 19450111
[TBL] [Abstract][Full Text] [Related]
16. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
[TBL] [Abstract][Full Text] [Related]
17. Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis.
Odetola FO; Gebremariam A; Freed GL
Pediatrics; 2007 Mar; 119(3):487-94. PubMed ID: 17332201
[TBL] [Abstract][Full Text] [Related]
18. Burden of aspergillosis-related hospitalizations in the United States.
Dasbach EJ; Davies GM; Teutsch SM
Clin Infect Dis; 2000 Dec; 31(6):1524-8. PubMed ID: 11096031
[TBL] [Abstract][Full Text] [Related]
19. Economic impact of heart failure in the United States: time for a different approach.
O'Connell JB; Bristow MR
J Heart Lung Transplant; 1994; 13(4):S107-12. PubMed ID: 7947865
[No Abstract] [Full Text] [Related]
20. Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs.
Esposito D; Bagchi AD; Verdier JM; Bencio DS; Kim MS
Am J Manag Care; 2009 Jul; 15(7):437-45. PubMed ID: 19589011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
